Assistant Physician News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Discovery, one that if true, could turn the whole pandemic around. This missouri woman, her name is patricia durgess, was licensed in missouri as an assistant physician. She had done med school at a school in the caribbean but she hadnt been accepted into a residency. She wasnt a full doctor. The rules say a person with midlevel professional accreditation like hers can only do so if they do it in collaboration with a fully accredited doctor. Theres nothing wrong with being a physician assistant, theres lots of room in our system for lots of different licensed professionals. But i think its saf...

Americans had already died from covid and we all knew it was going to get so, so much worse. The future was looking then, and would turn out to be, incredibly grim. On that same day, april 11, a woman in missouri said publicly she had made an important discovery, one that if true, could turn the whole pandemic around. This missouri woman, her name is Patricia Derges, was licensed in missouri as an assistant physician. She had done med school at a school in the caribbean but she hadnt been accepted into a residency. She wasnt a full doctor. The rules say a person with midlevel professional accr...

. good morning, everyone. welcome to "cnn this morning." it's december 31st. yes, it's the last day of the year. happy new year's eve to you, martin. >> happy new year's eve to you as well, amara. thank you. we are, of course, following breaking news this morning. pope benedict emeritus has died. pope francis had been asking for prayers. >> for the firstet time in modern history he resigned in 2013, citing advanced age, which paved the way for pope francis to head the church. cnn's delia gallagher with more. >> reporter: in many respects, benedict xvi was the pope who got a bad rap...

/PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by five new members. Led by Katerina Politi, PhD,...

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.